UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy

Hwang, Angela; Mehra, Vedika; Chhetri, Jyoti; Ali, Samira; Tran, Maxine; Roddie, Claire; (2024) Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy. Cancers , 16 (6) , Article 1209. 10.3390/cancers16061209. Green open access

[thumbnail of cancers-16-01209.pdf]
Preview
PDF
cancers-16-01209.pdf - Published Version

Download (1MB) | Preview

Abstract

Renal cell carcinoma (RCC) affects over 400,000 patients globally each year, and 30% of patients present with metastatic disease. Current standard of care therapy for metastatic RCC involve TKIs and ICIs, including combinatorial strategies, but this offers only modest clinical benefit. Novel treatment approaches are warranted, and cell-based immunotherapies for RCC hold significant promise. These are currently being tested in the pre-clinical setting and in early phase clinical trials. Here, we review the landscape of cellular immunotherapy for RCC in the context of currently available therapies, with a particular focus on defining the current best antigenic targets, the range of cell therapy products being explored in RCC, and how advanced engineering solutions may further enhance these therapies in the RCC space.

Type: Article
Title: Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy
Location: Switzerland
Open access status: An open access version is available from UCL Discovery
DOI: 10.3390/cancers16061209
Publisher version: https://doi.org/10.3390/cancers16061209
Language: English
Additional information: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Keywords: renal cell carcinoma; immunotherapy; chimeric antigen receptor (CAR) T-cells; engineered TCR T-cells
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: https://discovery.ucl.ac.uk/id/eprint/10190282
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item